Header Logo

Connection

PARTH MEHTA to Humans

Back to Details
This is a "connection" page, showing publications PARTH MEHTA has written about Humans.
PARTH MEHTA
Connection Strength
0.212
Humans
  1. Infantile Pyknocytosis: An Uncommon Cause of Newborn Hemolytic Anemia. J Pediatr Hematol Oncol. 2020 05; 42(4):e251-e253.
    View in: PubMed
    Score: 0.019
  2. Establishing a Pediatric Hematology-Oncology Program in Botswana. J Glob Oncol. 2018 09; 4:1-9.
    View in: PubMed
    Score: 0.017
  3. Proposal of a Risk-Stratification Platform to Address Distinct Clinical Features of Pediatric Kaposi Sarcoma in Lilongwe, Malawi. J Glob Oncol. 2018 09; 4:1-7.
    View in: PubMed
    Score: 0.016
  4. Identifying opportunities to bridge disparity gaps in curing childhood cancer in Malawi: Malignancies with excellent curative potential account for the majority of diagnoses. Pediatr Hematol Oncol. 2017 Aug; 34(5):261-274.
    View in: PubMed
    Score: 0.016
  5. Clinical Factors Associated with Long-Term Complete Remission versus Poor Response to Chemotherapy in HIV-Infected Children and Adolescents with Kaposi Sarcoma Receiving Bleomycin and Vincristine: A Retrospective Observational Study. PLoS One. 2016; 11(4):e0153335.
    View in: PubMed
    Score: 0.014
  6. Maximizing the Impact of a Pediatric Hematology-Oncology Twinning Program. Pediatr Blood Cancer. 2016 Feb; 63(2):369.
    View in: PubMed
    Score: 0.013
  7. Clinical characteristics and outcomes of HIV-infected children diagnosed with Kaposi sarcoma in Malawi and Botswana. Pediatr Blood Cancer. 2013 Aug; 60(8):1274-80.
    View in: PubMed
    Score: 0.011
  8. Essential medicines for pediatric oncology in developing countries. Pediatr Blood Cancer. 2013 May; 60(5):889-91.
    View in: PubMed
    Score: 0.011
  9. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome. J Pediatr Hematol Oncol. 2010 Oct; 32(7):532-6.
    View in: PubMed
    Score: 0.010
  10. Pediatric HIV+ Kaposi sarcoma exhibits clinical, virological, and molecular features different from the adult disease. JCI Insight. 2023 11 22; 8(22).
    View in: PubMed
    Score: 0.006
  11. Outcomes of Wilms tumor therapy in Lilongwe, Malawi, 2016-2021: Successes and ongoing research priorities. Pediatr Blood Cancer. 2023 05; 70(5):e30242.
    View in: PubMed
    Score: 0.006
  12. Divergent clinical presentations and outcomes among children and adolescents with Kaposi sarcoma in Malawi and Tanzania. HIV Med. 2023 06; 24(6):664-675.
    View in: PubMed
    Score: 0.006
  13. The Burden of Malnutrition in Childhood Cancer in Malawi - Risk Regardless of Age. Nutr Cancer. 2022; 74(9):3322-3328.
    View in: PubMed
    Score: 0.005
  14. Long-term outcomes for children and adolescents with Kaposi sarcoma. HIV Med. 2022 02; 23(2):197-203.
    View in: PubMed
    Score: 0.005
  15. Anemia at Intensive Care Unit Admission and Hospital Mortality Among Patients at a Referral Hospital in Malawi. Am Surg. 2021 Aug; 87(8):1334-1340.
    View in: PubMed
    Score: 0.005
  16. Recommendations for treating life-threatening Kaposi sarcoma during pregnancy in HIV-positive women in low income countries. Int J STD AIDS. 2020 07; 31(8):724-734.
    View in: PubMed
    Score: 0.005
  17. Factors influencing diagnostic delays of pediatric cancers in Botswana. Pediatr Blood Cancer. 2020 04; 67(4):e28182.
    View in: PubMed
    Score: 0.005
  18. Opportunities for improving retinoblastoma screening practices among physicians in Botswana. Pediatr Hematol Oncol. 2020 04; 37(3):269-271.
    View in: PubMed
    Score: 0.005
  19. Kaposi Sarcoma Herpesvirus Inflammatory Cytokine Syndrome-like Clinical Presentation in Human Immunodeficiency Virus-infected Children in Malawi. Clin Infect Dis. 2019 11 13; 69(11):2022-2025.
    View in: PubMed
    Score: 0.005
  20. Capacity building: a novel pediatric hematology-oncology fellowship program in sub-Saharan Africa. Blood Adv. 2018 11 30; 2(Suppl 1):11-13.
    View in: PubMed
    Score: 0.004
  21. KSHV viral load and Interleukin-6 in HIV-associated pediatric Kaposi sarcoma-Exploring the role of lytic activation in driving the unique clinical features seen in endemic regions. Int J Cancer. 2019 01 01; 144(1):110-116.
    View in: PubMed
    Score: 0.004
  22. Lessons From Pediatric HIV: A Case for Curative Intent in Pediatric Cancer in LMICs. Pediatrics. 2017 10; 140(4).
    View in: PubMed
    Score: 0.004
  23. Increasing Numbers of New Kaposi Sarcoma Diagnoses in HIV-Infected Children and Adolescents Despite the Wide Availability of Antiretroviral Therapy in Malawi. Clin Infect Dis. 2017 03 15; 64(6):818-819.
    View in: PubMed
    Score: 0.004
  24. Profound Vitamin B12 Deficiency in a 1-Year-Old Child in Botswana: A Call to Initiate Early Empiric Therapy. J Pediatr Hematol Oncol. 2016 08; 38(6):486-8.
    View in: PubMed
    Score: 0.004
  25. Mapping the Epidemiology of Kaposi Sarcoma and Non-Hodgkin Lymphoma Among Children in Sub-Saharan Africa: A Review. Pediatr Blood Cancer. 2016 08; 63(8):1325-31.
    View in: PubMed
    Score: 0.004
  26. Early antiretroviral therapy is protective against epilepsy in children with human immunodeficiency virus infection in botswana. J Acquir Immune Defic Syndr. 2015 Jun 01; 69(2):193-9.
    View in: PubMed
    Score: 0.003
  27. Paclitaxel for relapsed or recurrent HIV-associated pediatric Kaposi's sarcoma. AIDS. 2014 Mar 13; 28(5):800-2.
    View in: PubMed
    Score: 0.003
  28. Reply to "childhood cancer in Africa". Pediatr Blood Cancer. 2014 Aug; 61(8):1524.
    View in: PubMed
    Score: 0.003
  29. MDM2 inhibition sensitizes neuroblastoma to chemotherapy-induced apoptotic cell death. Mol Cancer Ther. 2006 Sep; 5(9):2358-65.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.